Bleomycin is a Intramuscular; Intrapleural; Intravenous; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Bleomycin Sulfate.
| Product ID | 69097-364_0014ce7e-f3e5-467c-a1a4-6bf8c2aefd3c |
| NDC | 69097-364 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bleomycin |
| Generic Name | Bleomycin |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2019-03-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209439 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | BLEOMYCIN SULFATE |
| Active Ingredient Strength | 15 [USP'U]/1 |
| Pharm Classes | Cytoprotective Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-03-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA209439 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-03-11 |
| Ingredient | Strength |
|---|---|
| BLEOMYCIN SULFATE | 15 [USP'U]/1 |
| SPL SET ID: | 497e462a-a295-4db1-9002-d2633efbd676 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9240 | Bleomycin | Bleomycin |
| 0143-9241 | Bleomycin | Bleomycin |
| 0409-0323 | Bleomycin | BLEOMYCIN |
| 0409-0332 | Bleomycin | BLEOMYCIN |
| 0703-3154 | Bleomycin | Bleomycin |
| 0703-3155 | Bleomycin | Bleomycin |
| 16714-886 | Bleomycin | Bleomycin |
| 16714-908 | Bleomycin | Bleomycin |
| 61703-323 | Bleomycin | BLEOMYCIN |
| 61703-332 | Bleomycin | BLEOMYCIN |
| 63323-136 | Bleomycin | BLEOMYCIN SULFATE |
| 63323-137 | Bleomycin | BLEOMYCIN SULFATE |
| 69097-364 | Bleomycin | Bleomycin |
| 70121-1567 | Bleomycin | Bleomycin |
| 71288-106 | Bleomycin | Bleomycin Sulfate |
| 71288-107 | Bleomycin | Bleomycin Sulfate |